Literature DB >> 18462925

Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.

Eric Dailly1, Ronan Le Floch, Guillaume Deslandes, Michel Pannier, Pascale Jolliet.   

Abstract

The relationship between clearance of vancomycin administered by continuous infusion and the glomerular filtration rate (GFR) estimated by creatinine clearance (CL(Cr)) was investigated in a large cohort of burn patients. Individual vancomycin clearance (CL(Van)) was estimated from the ratio between the rate of infusion and the plasma concentration at steady state for 70 patients (149 samples). The average value of CL(Van) (7.03+/-3.79 L/h) was higher than normal values in non-burn patients. A significant relationship between CL(Van) versus CL(Cr) was found (r=0.506; P<0.001): CL(Van) (L/h)=0.0205CL(Cr)(mL/min)+3.47. From this result, a simple formula is proposed to adapt vancomycin dosage: rate of vancomycin continuous infusion (g/day)=[0.0205CL(Cr) (mL/min)+3.47] x [target vancomycin concentration at steady state (mg/L)] x (24/1000). The limits of the predictive performance of this formula are discussed, since factors other than GFR can affect vancomycin elimination. This formula could help clinicians to define the optimum vancomycin dosage, particularly in patients with disturbed renal function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462925     DOI: 10.1016/j.ijantimicag.2008.02.008

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

Review 1.  Management of antimicrobial use in the intensive care unit.

Authors:  Francisco Álvarez-Lerma; Santiago Grau
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

Review 2.  Augmented renal clearance: implications for antibacterial dosing in the critically ill.

Authors:  Andrew A Udy; Jason A Roberts; Robert J Boots; David L Paterson; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

3.  Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis.

Authors:  Lyndsay M van de Vijsel; Sandra A N Walker; Scott E Walker; Sharon Yamashita; Andrew Simor; Michelle Hladunewich
Journal:  Can J Hosp Pharm       Date:  2010-05

Review 4.  Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.

Authors:  Christopher Giuliano; Christopher Giulano; Krystal K Haase; Ronald Hall
Journal:  Expert Rev Anti Infect Ther       Date:  2010-01       Impact factor: 5.091

5.  Use of Opioids and Outcomes of Pneumonia: Results From the US Nationwide Inpatient Sample.

Authors:  Yeongjun James Park; Chia-Hung Yo; Wan-Ting Hsu; Eric Po-Yang Tsou; Yu-Chiang Wang; Dean-An Ling; An-Fu Lee; Michael A Liu; Chien-Chang Lee
Journal:  J Acute Med       Date:  2021-12-01

6.  Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram.

Authors:  João Pedro Baptista; Jason A Roberts; Eduardo Sousa; Ricardo Freitas; Nuno Deveza; Jorge Pimentel
Journal:  Crit Care       Date:  2014-12-05       Impact factor: 9.097

7.  A specially tailored vancomycin continuous infusion regimen for renally impaired critically ill patients.

Authors:  Eman Mohamed Bahgat Eldemiry; Nirmeen A Sabry; Maggie M Abbassi; Sanaa S Abdel Shafy; Mohamed S Mokhtar; Ahmed Abdel Bary
Journal:  SAGE Open Med       Date:  2013-10-08

8.  A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance.

Authors:  Nor Asyikin Mohd Tahir; Shamin Mohd Saffian; Farida Hanim Islahudin; Abdul Halim Abdul Gafor; Mohd Makmor-Bakry
Journal:  J Korean Med Sci       Date:  2020-09-21       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.